Stay
up-to-date
about
RECOVER
Our understanding of Long COVID is constantly evolving with new research findings. Stay informed by reading the latest news and participating in upcoming events.
Results from a recent RECOVER study suggest that adults who have COVID-19 may be more likely to develop a related condition called myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS).
During the November 8th RECOVER Research Review (R3) Seminar, researchers presented their understanding of the biomarkers of PASC. Presenters discussed the need for biomarkers, early immunological findings, ultrasensitive viral antigen measurements, and markers of fungal translocation.
During the October 25th RECOVER Research Review (R3) Seminar, researchers presented on how symptoms following SARS-CoV-2 infection have been measured, the importance of understanding the scope of symptoms, and patient perception about the burden of various symptoms. Presenters discussed the development and validation of a symptom burden questionnaire, methods to assess symptoms among RECOVER adult cohort participants, and the development of a questionnaire to capture symptoms and their burdensomeness after COVID infection.
During the October 11th RECOVER Research Review (R3) Seminar, presenters discussed leveraging mobile health platform technologies to understand PASC. The seminar explored what is known about these technologies in PASC research, the gaps in our knowledge, and how RECOVER will contribute to filling these gaps.
During the September 27th RECOVER Research Review (R3) Seminar, researchers presented findings from autopsy studies on PASC. Presenters discussed what has been learned about PASC from autopsy studies, the gaps in our knowledge, and how RECOVER will contribute to filling these knowledge gaps.
During the September 13th RECOVER Research Review (R3) Seminar, researchers presented on the clinical spectrum of PASC with a focus on coagulopathies. Presenters discussed our current understanding of coagulopathies in PASC, the gaps in our knowledge, and how RECOVER will contribute to filling these knowledge gaps.
During the August 23rd RECOVER Research Review (R3) Seminar, researchers presented on the clinical spectrum of PASC with a focus on sleep. Presenters discussed our current understanding of sleep disturbances in PASC patients, the gaps in our knowledge, and how RECOVER will contribute to filling these knowledge gaps.
RECOVER has awarded over $37 million in funding to more than 40 pathobiology studies that will further our understanding of how COVID affects different body tissues and organs.
Media InquiriesAre you a member of the media or press? Please direct inquiries to the RECOVER@nih.gov inbox. Please place "MEDIA INQUIRY" in your subject line.